iMedicom

What iMedicom does

iMedicom (아이메디컴(주)) is a privately held South Korean medical device manufacturer founded in 2004 and headquartered in Gunpo-si, Gyeonggi-do. The company designs and manufactures surgical instruments and implants across four verticals: orthopedic surgery (battery-powered and pneumatic surgical handpieces such as MEDINAUT MAX and LEOPARD, saw blades, burrs, the EZX powered acetabular cup removal system, and the NEXTOSS synthetic bone substitute), spinal surgery (MEDINAUT balloon kyphoplasty/vertebroplasty systems, MVX bone cement, SPINAUT and EPINAUT epidural catheters), ENT surgery (SINUSCURE balloon sinuplasty and Eustachian tuboplasty systems), and veterinary medicine (ANIVERSE Patella Tracking System, PGR instrument, surgical handpieces, and rapid diagnostic test kits).

The company's product portfolio rests on several proprietary technology platforms: non-welded balloon catheter molding (KR 10-2072058), steerable catheter technology (KR 10-1544412), a noise-minimized oscillating saw (KR 10-1198242), the world's first powered acetabular cup removal system EZX (KR 10-1917301, NET-certified 2018), the EZImpactor separation-type powered THA impaction system (NET-certified 2022), the NEXTOSS 1mm-precision 100% β-TCP synthetic bone substitute, and the MEDINAUT MAX BLDC-powered multi-attachment handpiece. The corporate research institute has been in continuous operation since 2006 and was designated a 2026 Excellent Corporate Research Institute by the Korean Ministry of Science and ICT.

iMedicom operates a pure one-time hardware sales model. Products are sold directly to hospitals, surgeons, and veterinary clinics in Korea and exported to over 40 countries through an international distributor network, with demand generation driven primarily by participation in major medical device exhibitions (AAOS, Arab Health/MEDICA, EFORT, EUROSPINE, NASS, KIMES, Medical Fair Asia, London Vetshow) and complemented by veterinary Dry Lab seminars and the Korean Veterinary Medical Association's Vet Store closed marketplace. Pricing is not publicly disclosed and is set per inquiry. Regulatory certifications span FDA 510(k), CE, KFDA, China SFDA, ISO 13485, ISO 9001, MDSAP, and KGMP, providing market access across the US, EU, China, and Korea. CEO Ju Don-soo has led the company since October 2009, and the firm remains privately held with no disclosed external institutional investors.

Name

iMedicom

Legal name

IMEDICOM Co., Ltd.

Website

https://imedicom.co.kr

Company type

Private

Founded year

2004

Operating status

Operating

Headcount range

11–50 employees

Short description

iMedicom is a privately held South Korean medical device manufacturer founded in 2004 that designs and sells surgical handpieces, implants, and balloon catheter systems for orthopedic, spinal, ENT, and veterinary surgery across 40+ countries.

Ownership category

akta.pro rank

Product category

Orthopedic and Surgical Medical Devices

NAICS

Surgical Appliance and Supplies Manufacturing (339113), Surgical and Medical Instrument Manufacturing (339112)

SIC

Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Orthopedic Joint Reconstruction Implants (Hip/Knee/Shoulder/Elbow/Ankle) (HLAHAEAA)

akta.pro secondary industries

Orthopedic Trauma & Extremities Fixation (Plates/Screws/Nails/External Fixation) (HLAHAEAB), Orthopedic & Implantable Devices (Plates, Screws, TPLO, Prosthetics) (HLAMAFAE), Neurosurgical Implants & Cranial/CMF (Cranial Plates, Dural Repair, Shunts) (HLAHAEAD)

Keywords

• Orthopedic surgical instruments
• Spinal surgery devices
• Veterinary medical devices
• Balloon kyphoplasty systems
• Surgical handpiece systems

Headquarters

HQ city

Gunpo

HQ country

South Korea

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Technology or R&D, Supply Chain, Marketing or Sales, Operations

Revenue model

1. Medical Device Sales (Orthopedic, Spinal, ENT, Veterinary): IMEDICOM manufactures and sells a comprehensive range of surgical medical devices including surgical handpieces (battery/pneumatic), saw blades, burrs, powered acetabular cup removal systems (EZX), synthetic bone grafts (NEXTOSS), balloon kyphoplasty/vertebroplasty systems (MEDINAUT series), epidural catheters (SPINAUT series), balloon sinuplasty systems (SINUSCURE), veterinary implants, and rapid diagnostic test kits. Products are sold domestically in Korea and exported to over 40 countries through distribution networks. Revenue is generated through one-time product sales to hospitals, clinics, surgeons, and veterinary practices.

Go-to-market motion2 records

Distribution channels4 records

Marketing channels5 records

Core offering

iMedicom (IMEDICOM Co., Ltd.) is a Korean medical device manufacturer that designs, develops, and sells orthopedic, spinal, ENT (ear, nose, throat), and veterinary surgical instruments and implants. Its portfolio spans battery-powered and pneumatic surgical handpieces, saw blades, burrs, the EZX powered acetabular cup removal system, NEXTOSS synthetic bone graft substitutes, balloon kyphoplasty/vertebroplasty systems (MEDINAUT series), steerable epidural catheters (SPINAUT/EPINAUT), balloon sinuplasty systems (SINUSCURE), and veterinary implants and rapid diagnostic kits. Products are sold domestically and exported to over 40 countries through an international distribution network.

Product overview

iMedicom (아이메디컴) is a medical device manufacturer specializing in orthopedic, spinal, ENT (ear, nose, throat), and veterinary surgical products. The company offers a comprehensive portfolio of surgical instruments including battery-powered and pneumatic surgical handpieces (MEDINAUT MAX, LEOPARD, ZAGUAR), surgical cutting tools (SAW BLADE, BURR/NEURO BLADE, TPLO BLADE), and powered surgical systems (EZX acetabular cup removal system, EZIMPACTOR). For spinal procedures, iMedicom provides balloon kyphoplasty/vertebroplasty systems (MEDINAUT series), epidural catheters (SPINAUT series, EPINAUT), and bone cement (MVX). ENT offerings include balloon sinuplasty systems (SINUSCURE EZ/E). The company also serves the veterinary market with surgical instruments, the ANIVERSE Patella Tracking System for patellar luxation treatment, and rapid diagnostic test kits for animal infectious diseases. NEXTOSS synthetic bone substitute represents a world-first 1mm-precision cutting technology. Products are sold in over 40 countries with various certifications including FDA 510(k), CE, ISO13485, and Korean KFDA approvals.

Differentiator

Problem solved

Functional benefit

Brands

• ANIVERSE: Veterinary medical device brand for pet healthcare, including Patella Tracking System (PTS) for dogs with patellar luxation.
• NEXTOSS
• EZX
• MEDINAUT
• SINUSCURE
• SPINAUT

Products and services

• MEDINAUT MAX

Quantifiable outcome

• EZX acetabular cup removal system can complete cup removal in under 1 minute in some surgical cases
• +2 more outcomes

Named customers2 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature7 records

Partnerships

Two partnerships are on record, tiered core and minor.

• Bitrust Meditech (주식회사 비트러스트메디텍)coreStrategic or Co-development Partner · 27 August 2024IMEDICOM and Bitrust Meditech signed an MOU in August 2024 for the joint development and commercialization of veterinary hip joint implants (인공고관절 임플란트) for domestic and overseas markets. Bitrust Meditech brings 15+ years of experience in human artificial joint R&D and holds Korea's first veterinary medical device approvals, including the artificial patellar groove replacement system. IMEDICOM will leverage its global distribution network and marketing capabilities to introduce these products worldwide. Bitrust will focus on product quality, performance enhancement, and providing education and certification programs for veterinarians.
• Seoul St. Mary's Hospital, Catholic University of Korea (가톨릭대학교 서울성모병원)minorStrategic or Co-development Partner · 1 January 2014IMEDICOM signed an MOU with Seoul St. Mary's Hospital in June 2014 for R&D cooperation, focusing on collaborative research and development in medical device technology.

Scale indicators6 records

Recent moves6 records

Expansion highlights5 records

Market position

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/watch?v=oFqVmzdKcDs
• LinkedInlinkedin.com/company/imedicom-co-ltd

Compliance19 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about iMedicom